Nuwellis NUWE
NASDAQ NUWE
$1.13 -0.04 (-3.86%)
As of: Aug 20, 2026 · 3:59 PM EDT

Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026)

Nuwellis' (NUWE) quarterly Liabilities and Shareholders Equity came in at $7.0 million in Q1 2026, down 0.64% YoY from $7.0 million in Q1 2025, and up 13.78% on a QoQ basis from $6.1 million in Q4 2025.

Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Nuwellis (NUWE) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $7.0 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 0.64% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.3 million (up 1.6% YoY) and the FY2025 annual result came in at $6.1 million, down 37.98% from the prior year.
  • Liabilities and Shareholders Equity grew to $7.0 million in Q1 2026, from $6.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $26.1 million in Q1 2022 to a low of $6.1 million in Q4 2025.
  • A 5-year average of $12.5 million and a median of $9.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 63.95% — and 2025, when it soared 48.65%.
  • Tracing NUWE's Liabilities and Shareholders Equity over 5 years: stood at $24.7 million in 2022, then plunged by 60.4% to $9.8 million in 2023, then increased by 0.96% to $9.9 million in 2024, then sank by 37.98% to $6.1 million in 2025, then advanced by 13.78% to $7.0 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $7.0 million (Q1 2026), $6.1 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 Nuwellis 203,898.38 -3.72 Mn 1.50 Mn 9.13 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.13 Mn
Mar 31, 2026 6.96 Mn
Dec 31, 2025 6.12 Mn
Sep 30, 2025 7.98 Mn
Jun 30, 2025 9.20 Mn
Mar 31, 2025 7.01 Mn
Dec 31, 2024 9.86 Mn
Sep 30, 2024 6.73 Mn
Jun 30, 2024 6.19 Mn
Mar 31, 2024 6.66 Mn
Dec 31, 2023 9.77 Mn
Sep 30, 2023 11.43 Mn
Jun 30, 2023 15.55 Mn
Mar 31, 2023 18.48 Mn
Dec 31, 2022 24.67 Mn
Sep 30, 2022 18.44 Mn
Jun 30, 2022 22.00 Mn
Mar 31, 2022 26.11 Mn
Dec 31, 2021 30.42 Mn
Sep 30, 2021 34.10 Mn